Table 4.
Univariate and multivariate analyses of progression-free survival
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value | |
| Age | 0.93–3.59 | 0.080 | 1.15–4.74 | 0.020 |
| MTV | 0.10–1.10 | 0.072 | 0.08–1.01 | 0.051 |
| GLCM contrast | 0.25–1.07 | 0.076 | 0.18–1.09 | 0.075 |
| NGLDM busyness | 0.18–0.94 | 0.036 | 0.17–3.93 | 0.81 |
| GLZLM LZE | 0.25–1.01 | 0.055 | 0.26–3.01 | 0.85 |
| GLZLM LZLGE | 0.19–0.86 | 0.019 | 0.14–4.14 | 0.75 |
CI confidence interval, MTV metabolic tumour volume, GLCM grey-level co-occurrence matrix, NGLDM neighbourhood grey-level different matrix, GLZLM grey-level zone length matrix, LZE long-zone emphasis, LZLGE long-zone low grey-level emphasis